Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Karen D. Wright, MD

1 clinical trial

Clinical trial
A Phase I Study of Tovorafenib/DAY101 (Formerly TAK-580, MLN2480) for Children With Low-Grade Gliomas and Other RAS/RAF/MEK/ERK Pathway Activated Tumors
Status: Active (not recruiting), Estimated PCD: 2024-12-31